发明公开
- 专利标题: 5-AMINOACETYLAMINOSULFONANILIDE COMPOUND
- 专利标题(中): 5-氨基乙酰氨基磺酰胺化合物
-
申请号: EP94907051.0申请日: 1994-02-16
-
公开(公告)号: EP0685461A1公开(公告)日: 1995-12-06
- 发明人: YOSHIKAWA, Kensei Taisho Pharmaceutical Co., Ltd. , SAITO, Shiuji Taisho Pharmaceutical Co., Ltd. , SHIMAZAKI, Yohichi Taisho Pharmaceutical Co., Ltd. , KASHIWA, Mariko Taisho Pharmaceutical Co., Ltd. , HATAYAMA, Katsuo Taisho Pharmaceutical Co., Ltd.
- 申请人: TAISHO PHARMACEUTICAL CO. LTD
- 申请人地址: 24-1 Takata 3-chome Toshima-ku Tokyo 171 JP
- 专利权人: TAISHO PHARMACEUTICAL CO. LTD
- 当前专利权人: TAISHO PHARMACEUTICAL CO. LTD
- 当前专利权人地址: 24-1 Takata 3-chome Toshima-ku Tokyo 171 JP
- 代理机构: Tauchner, Paul, Dr.
- 优先权: JP29550/93 19930219
- 国际公布: WO9419318 19940901
- 主分类号: C07C311/08
- IPC分类号: C07C311/08 ; C07D295/15 ; A61K31/18
摘要:
An object of the invention is to provide a drug which is reduced in the side effects such as digestive tract disorder, has such a high safety as to permit long-term administration, and has anti-inflammatory, antipyretic, analgesic and and antiallergic activities. The drug comprises a compound represented by general formula (I) or a salt thereof, wherein R¹ represents phenyl, halophenyl or C₃-C₈ cycloalkyl; R² represents hydrogen or C₁-C₅ alkyl; and R³ represents hydrogen, C₁-C₇ alkyl, C₃-C₈ cycloalkyl, C₃-C₅ alkenyl or benzyl; or alternatively R² and R³ are combined together to represents a 5- to 7- membered heterocyclic group in combination with the nitrogen atom to which they are bonded.
信息查询